| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A4 ABCA2 SLC8B1 CLCN6 SLC31A2 PSG4 HPX SLC17A4 KCNMA1 SLC47A1 SLC35F2 GRIN2A SLC7A11 CNGB1 AQP7 ABCB1 | 1.76e-05 | 1180 | 81 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | ceramide floppase activity | 4.86e-05 | 3 | 81 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A4 ABCA2 SLC8B1 CLCN6 SLC31A2 PSG4 HPX SLC17A4 KCNMA1 SLC47A1 SLC35F2 GRIN2A SLC7A11 CNGB1 AQP7 ABCB1 | 5.14e-05 | 1289 | 81 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 6.18e-05 | 431 | 81 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 9.70e-05 | 4 | 81 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 1.61e-04 | 5 | 81 | 2 | GO:0004579 | |
| GeneOntologyMolecularFunction | oligosaccharyl transferase activity | 1.61e-04 | 5 | 81 | 2 | GO:0004576 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR7D4 VIPR1 OR1M1 OR7C2 OR7C1 ADGRB3 OR1E1 ADGRE5 OR7G3 OR7G2 OR7A2P OR2W6P | 2.23e-04 | 884 | 81 | 12 | GO:0004930 |
| GeneOntologyMolecularFunction | antiporter activity | 2.46e-04 | 138 | 81 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR7D4 VIPR1 OR1M1 IGF2R OR7C2 NRXN2 OR7C1 ADGRB3 OR1E1 ADGRE5 GRIN2A OR7G3 OR7G2 OR7A2P OR2W6P | 3.16e-04 | 1353 | 81 | 15 | GO:0004888 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 6.99e-04 | 477 | 81 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A4 SLC8B1 CLCN6 SLC31A2 SLC17A4 KCNMA1 SLC47A1 GRIN2A CNGB1 AQP7 | 9.64e-04 | 758 | 81 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.29e-03 | 296 | 81 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.36e-03 | 201 | 81 | 5 | GO:0061135 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.54e-03 | 207 | 81 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.58e-03 | 208 | 81 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | floppase activity | 1.88e-03 | 16 | 81 | 2 | GO:0140328 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR7D4 OR1M1 OR7C2 OR7C1 OR1E1 OR7G3 OR7G2 CNGB1 OR7A2P OR2W6P | 9.10e-06 | 432 | 83 | 10 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR7D4 OR1M1 OR7C2 OR7C1 OR1E1 OR7G3 OR7G2 CNGB1 OR7A2P OR2W6P | 1.72e-05 | 465 | 83 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR7D4 OR1M1 OR7C2 OR7C1 OR1E1 GRIN2A OR7G3 OR7G2 CNGB1 OR7A2P OR2W6P | 2.11e-05 | 582 | 83 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR7D4 OR1M1 OR7C2 OR7C1 OR1E1 OR7G3 OR7G2 CNGB1 OR7A2P OR2W6P | 2.47e-05 | 485 | 83 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR7D4 OR1M1 OR7C2 OR7C1 OR1E1 OR7G3 OR7G2 CNGB1 OR7A2P OR2W6P | 4.74e-05 | 524 | 83 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | co-translational protein modification | 4.79e-05 | 3 | 83 | 2 | GO:0043686 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 4.79e-05 | 3 | 83 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR7D4 OR1M1 OR7C2 OR7C1 OR1E1 OR7G3 OR7G2 CNGB1 OR7A2P OR2W6P | 6.79e-05 | 547 | 83 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR7D4 OR1M1 OR7C2 OR7C1 OR1E1 GRIN2A OR7G3 OR7G2 CNGB1 OR7A2P OR2W6P | 1.46e-04 | 722 | 83 | 11 | GO:0051606 |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 1.59e-04 | 5 | 83 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | adult behavior | 1.70e-04 | 203 | 83 | 6 | GO:0030534 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | OR7C2 OR7C1 SPTLC2 CYP8B1 MACO1 GRIN2A UBIAD1 LRBA SEZ6L2 OR7A2P TMEM86A STT3A STT3B PROS1 OR2W6P | 1.56e-04 | 1293 | 83 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | OR7C2 OR7C1 SPTLC2 CYP8B1 MACO1 GRIN2A UBIAD1 LRBA SEZ6L2 OR7A2P TMEM86A STT3A STT3B PROS1 OR2W6P | 1.64e-04 | 1299 | 83 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | OR7C2 OR7C1 SPTLC2 CYP8B1 MACO1 GRIN2A UBIAD1 LRBA SEZ6L2 OR7A2P TMEM86A STT3A STT3B PROS1 OR2W6P | 2.07e-04 | 1327 | 83 | 15 | GO:0042175 |
| Domain | STT3 | 1.90e-05 | 2 | 82 | 2 | PF02516 | |
| Domain | Oligo_trans_STT3 | 1.90e-05 | 2 | 82 | 2 | IPR003674 | |
| Domain | Olfact_rcpt | 3.28e-04 | 393 | 82 | 8 | IPR000725 | |
| Domain | GPCR_2_secretin-like_CS | 4.42e-04 | 34 | 82 | 3 | IPR017983 | |
| Domain | A2M_N_2 | 5.24e-04 | 8 | 82 | 2 | SM01359 | |
| Domain | - | 5.24e-04 | 8 | 82 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 5.24e-04 | 8 | 82 | 2 | SM01361 | |
| Domain | A2M | 5.24e-04 | 8 | 82 | 2 | SM01360 | |
| Domain | A2M_N | 8.38e-04 | 10 | 82 | 2 | PF01835 | |
| Domain | A2M_N | 8.38e-04 | 10 | 82 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 8.38e-04 | 10 | 82 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 8.38e-04 | 10 | 82 | 2 | PS00477 | |
| Domain | A2M | 8.38e-04 | 10 | 82 | 2 | PF00207 | |
| Domain | A2M_N_2 | 8.38e-04 | 10 | 82 | 2 | IPR011625 | |
| Domain | A2M_comp | 8.38e-04 | 10 | 82 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 8.38e-04 | 10 | 82 | 2 | PF07703 | |
| Domain | A2M_recep | 8.38e-04 | 10 | 82 | 2 | PF07677 | |
| Domain | A2M_comp | 8.38e-04 | 10 | 82 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 8.38e-04 | 10 | 82 | 2 | IPR001599 | |
| Domain | - | 1.22e-03 | 12 | 82 | 2 | 1.50.10.20 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.38e-03 | 50 | 82 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.38e-03 | 50 | 82 | 3 | PF00002 | |
| Domain | GPCR_2_secretin-like | 2.33e-03 | 60 | 82 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 2.33e-03 | 60 | 82 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.44e-03 | 61 | 82 | 3 | PS50261 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.78e-03 | 18 | 82 | 2 | IPR008930 | |
| Domain | AAA+_ATPase | 3.72e-03 | 144 | 82 | 4 | IPR003593 | |
| Domain | AAA | 3.72e-03 | 144 | 82 | 4 | SM00382 | |
| Domain | HormR | 5.35e-03 | 25 | 82 | 2 | SM00008 | |
| Domain | HRM | 6.68e-03 | 28 | 82 | 2 | PF02793 | |
| Domain | - | 8.45e-03 | 95 | 82 | 3 | 2.60.120.200 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 3.59e-09 | 219 | 85 | 9 | 12213199 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 1.57e-07 | 340 | 85 | 9 | 11875048 | |
| Pubmed | 1.57e-07 | 340 | 85 | 9 | 11802173 | ||
| Pubmed | 1.69e-07 | 343 | 85 | 9 | 32295537 | ||
| Pubmed | 1.82e-07 | 346 | 85 | 9 | 14611657 | ||
| Pubmed | 2.84e-07 | 23 | 85 | 4 | 10706615 | ||
| Pubmed | Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species. | 3.40e-07 | 24 | 85 | 4 | 9119360 | |
| Pubmed | OR7D4 OR1M1 OR7C2 OR7C1 OR1E1 OR3A4P OR7G3 OR7G2 OR7A2P OR2W6P | 8.41e-07 | 541 | 85 | 10 | 14983052 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 1.09e-06 | 74 | 85 | 5 | 15081110 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11487658 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28630426 | ||
| Pubmed | Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. | 5.90e-06 | 2 | 85 | 2 | 23842455 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31296534 | ||
| Pubmed | The middle X residue influences cotranslational N-glycosylation consensus site skipping. | 5.90e-06 | 2 | 85 | 2 | 25029371 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36139350 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22044667 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30181269 | ||
| Pubmed | Chromosomal location-dependent nonstochastic onset of odor receptor expression. | 9.35e-06 | 17 | 85 | 3 | 20668191 | |
| Pubmed | STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. | 1.77e-05 | 3 | 85 | 2 | 29765039 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19167329 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 33497605 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 24145140 | ||
| Pubmed | Keratinocyte-associated protein 2 is a bona fide subunit of the mammalian oligosaccharyltransferase. | 3.53e-05 | 4 | 85 | 2 | 22266900 | |
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 4.42e-05 | 28 | 85 | 3 | 31600191 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 22467853 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 6.67e-05 | 719 | 85 | 9 | 35337019 | |
| Pubmed | 7.41e-05 | 176 | 85 | 5 | 28692057 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 7.79e-05 | 569 | 85 | 8 | 30639242 | |
| Pubmed | OST4 is a subunit of the mammalian oligosaccharyltransferase required for efficient N-glycosylation. | 8.80e-05 | 6 | 85 | 2 | 23606741 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 12887896 | ||
| Pubmed | Differential expression of intestinal membrane transporters in cholera patients. | 1.23e-04 | 7 | 85 | 2 | 17575980 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 19844206 | ||
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 1.51e-04 | 42 | 85 | 3 | 29348145 | |
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 20110084 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 22456507 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A4 ABCA2 IGF2R SPTLC2 ADGRE5 UBIAD1 SEZ6L2 SLC7A11 STT3A STT3B PROS1 | 1.64e-04 | 1201 | 85 | 11 | 35696571 |
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 21707071 | ||
| Pubmed | 2.33e-04 | 225 | 85 | 5 | 12168954 | ||
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 20541250 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 2.64e-04 | 1061 | 85 | 10 | 33845483 | |
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 2.86e-04 | 52 | 85 | 3 | 24613359 | |
| Pubmed | 3.05e-04 | 371 | 85 | 6 | 15747579 | ||
| Pubmed | 3.19e-04 | 54 | 85 | 3 | 8482578 | ||
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 8004088 | ||
| Pubmed | Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B. | 3.20e-04 | 11 | 85 | 2 | 31831667 | |
| Pubmed | 3.20e-04 | 11 | 85 | 2 | 9647694 | ||
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 15835887 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 4.29e-04 | 732 | 85 | 8 | 34732716 | |
| Pubmed | Alternative splice variants encoding unstable protein domains exist in the human brain. | 4.52e-04 | 13 | 85 | 2 | 15491607 | |
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 16814779 | ||
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 4.52e-04 | 13 | 85 | 2 | 11014824 | |
| Pubmed | 5.27e-04 | 64 | 85 | 3 | 19729601 | ||
| Pubmed | 5.52e-04 | 65 | 85 | 3 | 23453885 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 6.03e-04 | 67 | 85 | 3 | 16987237 | |
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 6.93e-04 | 16 | 85 | 2 | 10673334 | |
| Pubmed | 7.17e-04 | 164 | 85 | 4 | 32409323 | ||
| Pubmed | 8.63e-04 | 300 | 85 | 5 | 19086053 | ||
| Pubmed | 8.80e-04 | 18 | 85 | 2 | 31791063 | ||
| Pubmed | IgSF21 promotes differentiation of inhibitory synapses via binding to neurexin2α. | 8.80e-04 | 18 | 85 | 2 | 28864826 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 9.04e-04 | 77 | 85 | 3 | 16944957 | |
| Pubmed | GGA2 and RAB13 promote activity-dependent β1-integrin recycling. | 9.83e-04 | 19 | 85 | 2 | 31076515 | |
| Pubmed | 1.09e-03 | 20 | 85 | 2 | 21072184 | ||
| Pubmed | 1.15e-03 | 657 | 85 | 7 | 36180527 | ||
| Pubmed | A series of recombinant inbred strains between the BALB/cHeA and STS/A mouse strains. | 1.20e-03 | 21 | 85 | 2 | 4042679 | |
| Pubmed | 1.20e-03 | 21 | 85 | 2 | 23137377 | ||
| Pubmed | 1.32e-03 | 22 | 85 | 2 | 27824289 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 1.42e-03 | 499 | 85 | 6 | 22810586 | |
| Pubmed | 1.44e-03 | 23 | 85 | 2 | 8799160 | ||
| Pubmed | 1.44e-03 | 23 | 85 | 2 | 34473953 | ||
| Pubmed | 1.55e-03 | 202 | 85 | 4 | 29540532 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 1.69e-03 | 516 | 85 | 6 | 36610398 | |
| Pubmed | 1.99e-03 | 27 | 85 | 2 | 31505254 | ||
| Pubmed | 2.03e-03 | 102 | 85 | 3 | 10231032 | ||
| Pubmed | Distribution of olfactory receptor genes in the human genome. | 2.14e-03 | 28 | 85 | 2 | 9500546 | |
| Pubmed | 2.14e-03 | 28 | 85 | 2 | 19352218 | ||
| Pubmed | 2.14e-03 | 28 | 85 | 2 | 34963058 | ||
| Pubmed | 2.21e-03 | 1168 | 85 | 9 | 19946888 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.18e-04 | 797 | 85 | 8 | chr19p13 | |
| GeneFamily | Olfactory receptors, family 7 | 1.46e-06 | 113 | 57 | 6 | 154 | |
| GeneFamily | STT3 oligosaccharyltransferase catalytic subunits|Oligosaccharyltransferase complex subunits | 9.77e-06 | 2 | 57 | 2 | 444 | |
| GeneFamily | Solute carriers | 2.32e-04 | 395 | 57 | 7 | 752 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.47e-04 | 9 | 57 | 2 | 1234 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 6.32e-04 | 12 | 57 | 2 | 445 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-06 | 196 | 84 | 6 | 08714b70ddaee7d11397c1dd4a287d412edd90f7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-06 | 196 | 84 | 6 | 5bcc959db7deb34d5a32d3464367d47d4945cdaf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-06 | 197 | 84 | 6 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 198 | 84 | 6 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 8.44e-06 | 146 | 84 | 5 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.97e-05 | 174 | 84 | 5 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 176 | 84 | 5 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 181 | 84 | 5 | e6c78038b14100e0c9c6fe25e8f0b75c02c33549 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.57e-05 | 184 | 84 | 5 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.78e-05 | 187 | 84 | 5 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 2.85e-05 | 188 | 84 | 5 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 2.85e-05 | 188 | 84 | 5 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.23e-05 | 193 | 84 | 5 | b53ffef20f918b7d1e9d3924562691d13245e2dd | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.65e-05 | 198 | 84 | 5 | 326e97bdc27cc3440f5488c2519446580cdc9d51 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.74e-05 | 199 | 84 | 5 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.74e-05 | 199 | 84 | 5 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.74e-05 | 199 | 84 | 5 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Transverse-T_cell-Tfh|Transverse / Region, Cell class and subclass | 3.74e-05 | 199 | 84 | 5 | cbef8f95edf2e86e16c448a76068d7ed8f6b7748 | |
| ToppCell | Transverse-(1)_T_cell-(16)_Tfh|Transverse / shred on region, Cell_type, and subtype | 3.74e-05 | 199 | 84 | 5 | aa31e26d48066f865ca33251a33a28934c0a7a44 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.74e-05 | 199 | 84 | 5 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.83e-05 | 200 | 84 | 5 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.83e-05 | 200 | 84 | 5 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.90e-05 | 116 | 84 | 4 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.31e-04 | 137 | 84 | 4 | 05ca83c30e3dbe74c81278b3636d57da2c20b458 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-04 | 143 | 84 | 4 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-04 | 143 | 84 | 4 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-04 | 148 | 84 | 4 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 149 | 84 | 4 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 149 | 84 | 4 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-04 | 151 | 84 | 4 | 9702575e47ececcf0a9f0f20a4a920dbb1ba5657 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-04 | 151 | 84 | 4 | 0cc2f4aec3dae4603fa831f22c40f897e68b34e2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-04 | 151 | 84 | 4 | b545823113a3450c5f841f7de48bf0937593544f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-04 | 151 | 84 | 4 | 673e4ab117b723c14d1df3804bbedc9e48284a9d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 151 | 84 | 4 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 155 | 84 | 4 | 29c4e9947bb4f7e257ed5c3bcf21bd67f88d473f | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-04 | 155 | 84 | 4 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 155 | 84 | 4 | fa2776d258e0420b2895de1008e292ad7725dac0 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 156 | 84 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 160 | 84 | 4 | 6393e3d5c5c8176c93aecd89b313bd054a00d474 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 160 | 84 | 4 | 2065938e944eb99478fd8132c2c03adeaee6d447 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-04 | 161 | 84 | 4 | afc719ffa53ab34c5628da47936da1f731dceab1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 167 | 84 | 4 | 2ca1b994583edf4e197535ffac8fb0c1142f0dc1 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.87e-04 | 168 | 84 | 4 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.00e-04 | 170 | 84 | 4 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(Ndrg2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.01e-04 | 69 | 84 | 3 | 3f6902cb62d6130b3d3a1cf122dbc695f7349ffe | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(Ndrg2)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.01e-04 | 69 | 84 | 3 | 832ed163f553481b49bbf8a1eb10cbd8afab4e34 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.14e-04 | 172 | 84 | 4 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-04 | 172 | 84 | 4 | 13d7117f92a92d77d6b4335ed800c585dc8b4511 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-04 | 172 | 84 | 4 | 3d83b2f03ad3af4dae3fe6cc0a0ef356872ca94f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-04 | 172 | 84 | 4 | a3d431aed12c1192e8dca1dc85b8340fb7354f8d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.14e-04 | 172 | 84 | 4 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-04 | 172 | 84 | 4 | 028a5441242b2cc760cafc1822120180619c63ae | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-04 | 172 | 84 | 4 | 9fc70b1a143a8ec910336c23b761d908bb6aecb2 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-04 | 173 | 84 | 4 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 3.28e-04 | 174 | 84 | 4 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-04 | 175 | 84 | 4 | bffa623511ceb0b9bf76d87f9a10cfadfe0e940f | |
| ToppCell | NS|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.72e-04 | 180 | 84 | 4 | 8472dcce7bc0b7ce428ec17ddf0018f3258f78d2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-04 | 183 | 84 | 4 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 4.05e-04 | 184 | 84 | 4 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.13e-04 | 185 | 84 | 4 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.22e-04 | 186 | 84 | 4 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.22e-04 | 186 | 84 | 4 | c984e5729958237b101df96d1c89a236faacded6 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-04 | 187 | 84 | 4 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.39e-04 | 188 | 84 | 4 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.39e-04 | 188 | 84 | 4 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | Healthy_donor-NK_CD56bright|World / disease group, cell group and cell class (v2) | 4.39e-04 | 188 | 84 | 4 | 8ee359199c61c3b5b498ac35148390db5cc1a836 | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.48e-04 | 189 | 84 | 4 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.48e-04 | 189 | 84 | 4 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | Control-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 4.57e-04 | 190 | 84 | 4 | 1584c68b58c7f406d9b0e8451beea3e6f8980c56 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.66e-04 | 191 | 84 | 4 | 04faa7d2237e45418611153294eb6f7bb690cbde | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.66e-04 | 191 | 84 | 4 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-04 | 191 | 84 | 4 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.75e-04 | 192 | 84 | 4 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-04 | 81 | 84 | 3 | 8cb94dda18010b3b05e5ab72235850483013c03a | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 4.84e-04 | 193 | 84 | 4 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | 4.84e-04 | 193 | 84 | 4 | f110f86db305e41639087f5b1a2dff103c07adf0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.94e-04 | 194 | 84 | 4 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.94e-04 | 194 | 84 | 4 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.94e-04 | 194 | 84 | 4 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 4.94e-04 | 194 | 84 | 4 | 5c58a2d1dd3c8ff77ce44d473239685e6b020909 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.94e-04 | 194 | 84 | 4 | ae5357e2a276473cde1fc8c43acaf9f69da35fd7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.94e-04 | 194 | 84 | 4 | 3a0b8b5d0354c43da57bb951cd8ba878363c3de5 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Ngfr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.00e-04 | 82 | 84 | 3 | cefd8c6f60ef27fb8823faddca1cf8bbd636f474 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Ngfr-Inhibitory_Neuron.Chat-Gad1Gad2-Slc17a8.Ngfr_(Globus_Pallidus/Nucleus_Basalis_(GP/NB),_cholinergic)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.00e-04 | 82 | 84 | 3 | 1ed7d7f70f00d6e280cd59c54e710bb724c8b50b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Ngfr-Inhibitory_Neuron.Chat-Gad1Gad2-Slc17a8.Ngfr_(Globus_Pallidus/Nucleus_Basalis_(GP/NB),_cholinergic)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.00e-04 | 82 | 84 | 3 | a5d3c5b7012d8ca7418670242d22aad3ed8c5191 | |
| ToppCell | T/NK_cells-CD56bright_NK_cell|T/NK_cells / Lineage and Cell class | 5.04e-04 | 195 | 84 | 4 | d2c8f5c114b1864b509fad449aa4492dfc61113c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.04e-04 | 195 | 84 | 4 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 5.04e-04 | 195 | 84 | 4 | 789149fb52d9d16393e1649358515add60d37f2d | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.04e-04 | 195 | 84 | 4 | ed41e709523cc3b86b1090d4fc0938ed47cb1fc9 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.04e-04 | 195 | 84 | 4 | fa5fc6f605deb5cae96eec14ba4000b19f877ba6 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 5.04e-04 | 195 | 84 | 4 | 731a454e45c7b610e0140312bcabaea711dcc766 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-04 | 195 | 84 | 4 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 5.04e-04 | 195 | 84 | 4 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.13e-04 | 196 | 84 | 4 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.13e-04 | 196 | 84 | 4 | bc4628d959d76c16981ac3b943f7c3fbbba49391 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-04 | 196 | 84 | 4 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.13e-04 | 196 | 84 | 4 | 5b5cf6f70534661d694f47359b6595b4580876c3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.13e-04 | 196 | 84 | 4 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| Computational | Genes in the cancer module 470. | 3.95e-05 | 16 | 46 | 3 | MODULE_470 | |
| Disease | congenital disorder of glycosylation Iw (implicated_via_orthology) | 6.90e-06 | 2 | 78 | 2 | DOID:0080572 (implicated_via_orthology) | |
| Disease | Edema, Cardiac | 2.07e-05 | 3 | 78 | 2 | C0013608 | |
| Disease | response to tenofovir | 3.38e-04 | 51 | 78 | 3 | EFO_0009279 | |
| Disease | Autistic Disorder | 6.50e-04 | 261 | 78 | 5 | C0004352 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 7.08e-04 | 15 | 78 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.83e-03 | 91 | 78 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | malaria (is_implicated_in) | 1.83e-03 | 24 | 78 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | TEMPS-A questionnaire | 1.99e-03 | 25 | 78 | 2 | EFO_0004783 | |
| Disease | systemic mastocytosis | 1.99e-03 | 25 | 78 | 2 | MONDO_0016586 | |
| Disease | amino acid measurement | 2.11e-03 | 678 | 78 | 7 | EFO_0005134 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.32e-03 | 27 | 78 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.46e-03 | 101 | 78 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLKLIYYSVGAGITD | 61 | A0A0A6YYG2 | |
| IYSYGKTSGLVVESG | 186 | Q9Y614 | |
| VYGAGSSLYGGTITI | 306 | Q5VTR2 | |
| STLVKGVIYGSYSVS | 31 | O60242 | |
| VDTGNVKGYVYSSFL | 626 | Q9NXL2 | |
| EISFSYYLIGKGSLV | 486 | A8K2U0 | |
| IVGVSAAIYSKGYGR | 666 | P48960 | |
| FSVQYVYGSGKKYIG | 31 | P53420 | |
| ITSVDKSYGGYEVVG | 286 | Q15517 | |
| VAAGGQKGKSYYTIT | 816 | Q9UPW5 | |
| VYLVGTVVGGRLTYT | 496 | Q9H2T7 | |
| GDSGVGKTTFLYRYT | 16 | O00194 | |
| GYTKLVGVFHTEYGA | 176 | Q9UFN0 | |
| LSVVSIFYGTGLGVY | 246 | Q8NGA2 | |
| LGKTFRLVGYTIQYG | 6 | Q96LU5 | |
| YGTTLVLSGEYSIGQ | 316 | P08183 | |
| ISYFTKGEYILLGGS | 286 | Q9HBG6 | |
| STVGYGDVYAKTTLG | 351 | Q12791 | |
| FLSVAVGSTVYYQGK | 151 | O14931 | |
| YRTTGGILDFYIVLG | 1161 | Q2M2H8 | |
| FVSKYLATIGIDYGV | 41 | Q9NZQ0 | |
| VNYGLGTLVKYSFTG | 176 | Q5MY95 | |
| IYAGVYSATFLEGII | 3966 | Q5CZC0 | |
| GTVFAYGQTGTGKTY | 91 | O14782 | |
| TEGIYGSTFLYLKFL | 21 | Q8N5G2 | |
| ALKYVLYTLVGFVGF | 1291 | Q96RV3 | |
| VISFYYGGKLVGQAT | 206 | Q02556 | |
| LISYGYVGGTVLRIK | 221 | Q8NHA6 | |
| VGIFYGTGVFSYTRL | 251 | P47883 | |
| GYKAIFVTVDTPYLG | 151 | Q9UJM8 | |
| GTTYIFGKGGALITY | 1136 | Q9P2S2 | |
| IFAIYQLGLGYKGTF | 376 | P50851 | |
| SYTVVLYGPAGLGKT | 206 | Q9NX02 | |
| YLGGIIYLVFIGSTI | 266 | O14520 | |
| FLLCGVLYVVYSTGG | 321 | Q6UWY5 | |
| CVVSLFYGTGLGVYL | 246 | Q8NG98 | |
| TTYIFGKGGALITYT | 91 | P58401 | |
| SVVTLFYGTGFGVYL | 246 | O76099 | |
| VLKSYIGLGHIYSGT | 506 | P51797 | |
| TVVYGITTGFGKFAR | 161 | P42357 | |
| SLAVLGGKLYVSGGY | 506 | Q9UJP4 | |
| IFLGVVLGSAVGYYL | 121 | O15432 | |
| KYLYIAVTVIESTGG | 321 | P01031 | |
| GTIYDYQFVTEGIGK | 1911 | Q8WXX0 | |
| GSKYFALYEVAGVGI | 861 | Q9BZC7 | |
| GKIAVISGVGTRNYY | 516 | Q9H9T3 | |
| ATVLVGEYLSISFYG | 91 | Q9BY19 | |
| VVGVTVSAGGYYAYK | 51 | Q8TDB4 | |
| LGLSGLVGTVTRTYY | 16 | Q6MZM0 | |
| GTAYYGLLGITKNVF | 756 | Q14689 | |
| LIYGPFGTGKTYTLA | 541 | Q9BYK8 | |
| TLFIFGVTKYIAGPY | 201 | Q00888 | |
| IPSGYVAGIFGAKYV | 126 | Q9Y2C5 | |
| ISGRYVSIGKFGTCY | 3416 | Q9NZJ4 | |
| ILFTAGYLSLFGYTK | 176 | Q9UNU6 | |
| VVSLFYGTGLGVYLS | 246 | O60412 | |
| VLTLQSGTYGVYEIG | 371 | Q6J4K2 | |
| SVVSLFYGTVIGLYL | 246 | P30953 | |
| SVVALFYGTTIGVYL | 246 | Q8NGA1 | |
| VVLGKGTYGIVYAGR | 656 | Q6ZN16 | |
| TYIGGVTFSGSLIAY | 746 | Q13423 | |
| VQGTQVYVFLTKGGY | 321 | P02790 | |
| VYVFLTKGGYTLVSG | 326 | P02790 | |
| GVIGDKVVVTYSKGY | 2066 | P11717 | |
| GIGGITTSTQFYYKL | 336 | Q9UQF0 | |
| PGSGVTGYLKVTIYA | 276 | A0AVI2 | |
| TGYLKVTIYALGVGD | 281 | A0AVI2 | |
| SIVLLFYGAGLGVYI | 246 | Q8NG99 | |
| FYGAGLGVYISSVVT | 251 | Q8NG99 | |
| IVVSLFYGTGFGVYL | 246 | Q8NG95 | |
| SYVLVIFGGLTGYSS | 576 | P46977 | |
| VTQTYGAAAGKGTYV | 396 | Q9Y4P8 | |
| GEVYGVVKAYTTRVG | 291 | P30520 | |
| VIVLGSGVYIYYTKL | 856 | Q6UXD5 | |
| GYKFSGLYILSFTVI | 311 | Q8IXU6 | |
| LVTVEKGSYYPGSGI | 476 | P07225 | |
| KVGAIVNTIGYYVVG | 406 | Q96FL8 | |
| YYFAVKTLITIGGLP | 836 | Q14028 | |
| GTTIKKSGGHYTYIL | 101 | Q9UPY5 | |
| GAFTYLVGVYVALIG | 141 | Q8N2M4 | |
| SVKTGYTIGYGLSLA | 141 | P32241 | |
| AVLTYVGYGVLTLFG | 71 | O15270 | |
| AGAVFLSVIYLTYTG | 361 | Q8TCJ2 | |
| YTLLGIYTGSGVLAV | 201 | Q86WB7 | |
| SFLYTGGIGFKYVAL | 171 | Q9Y5Z9 | |
| GSLVTLTFGGAYVVK | 476 | P31645 | |
| LAFTGVAGYITYLSI | 151 | Q8N2U9 | |
| DGYVVKETIGVGSYS | 416 | Q15418 | |
| KLVTIGSGYIFATTG | 746 | Q12879 |